The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
Here are six factors to consider and discuss with your doctor before transitioning to a biologic for moderate to severe Crohn's disease.
A drug that’s derived from living things and often administered by self-injection? Yeah, you’ve (understandably) got questions about biologic drugs—and we’ve got a handful you can go ahead and add to ...
The FDA granted Fast Track designation to the investigational biologic combination therapy COYA 302 for amyotrophic lateral sclerosis treatment.
Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its association ...
Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...
Psoriasis treatment has come a long way in the last 30 years. There’s no cure, but medication can help you gain control of your symptoms. If your current treatment doesn’t help enough, the doctor ...
When Howard Chang, 50, first learned about biologic treatments for psoriasis almost 20 years ago, he was eager to give them a try. Now they’re a mainstay in his overall treatment plan. Chang was first ...
CORRECTED April 15, 2024 // An earlier version of this article stated incorrect percentages of patients who never received any biologics during the study's 3-year period but improved rapidly or ...
After 1 year, overall treatment switch rates were 14.4%, while after 2 years, switch rates were 26%. Switching therapies was common in patients with psoriasis who used biologics over the course of 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results